|
|
Article: ALK-Abello's Grazax launched in Germany.(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- November 27, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Danish drugmaker ALK-Abello has launched its tablet-based vaccine against grass pollen allergy, Grazax, in Germany. The agent is the first allergy tablet to address the underlying cause of allergic rhinitis and not just treat the symptoms. It will subsequently be introduced in other ...
Related newspaper, magazine, and journal articles:
|
|
Article: Alk-Abello's Grazax for children launched in UK.(Brief ...
Pharma Marketletter;
March 2, 2009 ;
644 words
...Danish firm ALK-Abello's Grazax, a tablet ... immunotherapy product for grass pollen allergy, is now available ... during the peak grass pollen season. Adding Grazax ... medications during the peak grass pollen season, noted Alk-Abello.
|
|